Pamela Skrabek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pamela Skrabek has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Abedallah Balusha
Department of Internal Medicine, Section on Neurology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada
1 shared publication- Brian G. Weinshenker
Department of Neurology, Mayo Clinic, Rochester, MN
1 shared publication - Caterina Giannini
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA
1 shared publication - Claudia Francesca Lucchinetti
Department of Neurology, Mayo Clinic, Rochester, MN, United States
1 shared publication - Eoin Patrick Flanagan
Department of Neurology, Mayo Clinic, Rochester, MN
1 shared publication - Michel Toledano
Department of Neurology, Mayo Clinic, Rochester, MN
1 shared publication
Latest Publications
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 13 (4) , e200607
Immunity Gone Viral
Subacute cognitive decline and imbalance in aquaporin-4-antibody-seropositive neuromyelitis optica spectrum disorder (AQP4+NMOSD) treated with mycophenolate has a broad differential diagnosis, including cerebral involvement of AQP4+NMOSD, infections, or other complications of immunosuppression. In this article, we highlight the diagnostic and treatment approach in a patient with AQP4+NMOSD who developed multifocal brain lesions.
- 1 July 2026
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 13 (4) , e200607
Open AccessImmunity Gone Viral
Subacute cognitive decline and imbalance in aquaporin-4-antibody-seropositive neuromyelitis optica spectrum disorder (AQP4+NMOSD) treated with mycophenolate has a broad differential diagnosis, including cerebral involvement of AQP4+NMOSD, infections, or other complications of immunosuppression. In this article, we highlight the diagnostic and treatment approach in a patient with AQP4+NMOSD who developed multifocal brain lesions.